Continuing education system for medicines regulatory authorities: a proposal applied in El Salvador
Keywords:
Education; Continuing; Drug and Narcotic Control; Health Authorities; Professional Competence; El SalvadorAbstract
Introduction: Strengthening regulatory functions in health is essential to ensure safe, effective, and quality medicines, with the performance of professionals being a strategic element. Although continuing education is key to developing regulatory competencies, in El Salvador there are gaps in technical knowledge, regulatory updates, and transversal skills.
Objective: To design a continuing education system aimed at healthcare professionals responsible for pharmaceutical regulation processes in El Salvador, in order to develop the necessary competencies for carrying out these processes.
Method: A technological development research was carried out, supported by the use of theoretical and empirical methods. This made it possible to present a diagnosis of the initial situation, the theoretical foundation, and the development of the continuing education system. The proposal was assessed through consultation with key users and specialists.
Results: The system integrates a competency-based approach, progressive training levels, flexible modalities, active methodologies, and evaluation and accreditation mechanisms. A high degree of relevance and feasibility is evidenced, highlighting its potential as a tool for human talent management in regulatory authorities, supported by the assessment of users and specialists who reaffirm the applicability and alignment of the system with international standards.
Conclusion: The proposed continuing education system is a comprehensive and viable strategy that, through the strengthening of regulatory capacities and institutional coordination, improves human talent management and the quality of pharmaceutical processes, thus contributing to the protection of public health in El Salvador.
Downloads
References
1. Organización Panamericana de la Salud. Control de calidad de medicinas - OPS/OMS. [Internet]. 2021. [citado el 27 de julio 2025]. Disponible en: https://www.paho.org/es/temas/aseguramiento-calidad-tecnologias-sanitarias
2. Gwaza L, Chemwolo A, Musonda M, Kuwana R, Dube A. Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products. Front. Med. Sec. Regulatory Science. [Internet]. 2024. [citado el 22 de Agosto 2025]. 11. Disponible en: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1394562/full.
3. Reid A, Staz M, Chaudhry HJ. Regulatory Authorities and Continuing Education Around the World: Adapting to COVID-19. J Eur CME. [Internet]. 2021 [citado el 23 de agosto de 2025]. 10(1). Disponible en: https://www.tandfonline.com/doi/pdf/10.1080/21614083.2021.2014095
4. Tran D, Tofade T, Thakkar N, Rouse M. US and International Health Professions’ Requirements for Continuing Professional Development. Am J Pharm Educ. [Internet]. 2014. [citado el 23 de agosto de 2025]. 78(6):129. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC4140495/
5. Sherman L, Halila H, Chappell K. An Overview of Continuing Medical Education/Continuing Professional Development Systems in Europe: A Mixed Methods Assessment. Journal of CME. [Internet]. 2024. [citado el 23 de agosto de 2025]. 13(1). Disponible en: https://www.tandfonline.com/doi/full/10.1080/28338073.2024.2435731#d1e189
6. Ceballos M, Salazar Ospina A, Sabater Hernández D, Amariles P. Effectiveness of a continuing education program of drugs with fiscalized substance to improve pharmacy staff competencies: a multicenter, cluster-randomized controlled trial. Pharm Pract. [Internet]. 2022. [citado el 23 de agosto de 2025]. 20(3):01–10. Disponible en: https://pharmacypractice.org/index.php/pp/article/view/2632
7. Schaefer R, Stein J, Niven L, Hill M, Kaagman O, Gerrits AJ, et al. Rethinking the Impact of Single Continuing Educational Activities: Navigating Complexity Through Insights from Real-World Evaluation and Contemporary Literature. Journal of CME. [Internet]. 2025. [citado el 23 de agosto de 2025]. 14(1):2498292. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC12077434/
8. Parada A. El Salvador. ¿Avance en salud o riesgo para los salvadoreños por proyecto de Ley de Ensayos Clínicos?. Salud y Fármacos. [Internet]. 2025. [citado el 23 de agosto de 2025]. Disponible en: https://www.saludyfarmacos.org/lang/en/boletin-farmacos/boletines/may202506/24_el/
9. Fernández Luque AM, Ramírez Montoya MS. Competencias de los Profesionales Sanitarios en el Marco de la Complejidad: Modelo de Formación Digital para la Educación 4.0. Revista Española de Documentación Científica. [Internet]. 2024. 47(2), e383. Disponible en: https://redc.revistas.csic.es/index.php/redc/article/view/1470/2359
10. Masava B, Nyoni CN, Botma Y. Standards for Scaffolding in Health Sciences Programmes: A Delphi Consensus Study. J Med Educ Curric Dev. [Internet]. 2023. [citado el 23 de agosto de 2025]. 10. Disponible en: https://journals.sagepub.com/doi/10.1177/23821205231184045
11. Masava B, Nyoni CN, Botma Y. Scaffolding in Health Sciences Education Programmes: An Integrative Review. Med Sci Educ. [Internet]. 2022. [citado el 23 de agosto de 2025]. 33(1):255. Disponible en: https://link.springer.com/article/10.1007/s40670-022-01691-x
12. World Health Organization. Towards a global competency framework for regulators of medical products. WHO Drug Information [Internet]. 2019 [citado el 22 de marzo de 2026]. 33(1):6–9. Disponible en: https://iris.who.int/bitstream/handle/10665/330894/DI331-6-9-eng.pdf
13. Tamiru H, Huluka SA, Negash B, Hailu K, Mekonen ZT. National Continuing Professional Development (CPD) training needs of pharmacists in Ethiopia. Hum Resour Health. [Internet]. 2023. [citado el 4 de septiembre de 2025]. 21(1):87. Disponible en: https://human-resources-health.biomedcentral.com/articles/10.1186/s12960-023-00873-x
14. Hajj A, Zeenny RM, Sacre H, Akel M, Haddad C, Salameh P. Pharmacy education and workforce: strategic recommendations based on expert consensus in Lebanon. J Pharm Policy Pract. [Internet]. 2023. [citado el 22 de agosto de 2025]. 16(1):1. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36593528/
15. Soklaridis S, Shier R, Zaheer R, Scully M, Williams B, Daniel SJ, et al. “The genie is out of the bottle”: a qualitative study on the impact of COVID-19 on continuing professional development. BMC Med Educ. [Internet]. 2024. [citado el 23 de agosto de 2025]. 24(1):1–11. Disponible en: https://bmcmededuc.biomedcentral.com/articles/10.1186/s12909-024-05498-9
16. Hajj A, Zeenny RM, Sacre H, Akel M, Haddad C, Salameh P. Pharmacy education and workforce: strategic recommendations based on expert consensus in Lebanon. J Pharm Policy Pract. . [Internet]. 2023. [citado el 4 de septiembre de 2025]. 16(1). Disponible en: https://www.tandfonline.com/doi/full/10.1186/s40545-022-00510-3
17. Batista JPB, Torre C, Sousa Lobo JM, Sepodes B. A review of the continuous professional development system for pharmacists. Hum Resour Health. [Internet]. 2022. [citado el 4 de septiembre de 2025]. 20(1):3. Disponible en: https://human-resources-health.biomedcentral.com/articles/10.1186/s12960-021-00700-1
18. Agencia Española de Medicamentos y Productos Sanitarios. Buenas Prácticas del Sistema Español de FARMACOVIGILANCIA de Medicamentos de Uso Humano. AEMPS. [Internet]. 2021. [citado el 30 de marzo de 2026]. Disponible en: https://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/SEFV-H/docs/Buenas-practicas-farmacovigilancia-SEFV-H.pdf.
19. Sanaeifar E, Houshmand E, Moghri J, Vejdani M, Tabatabaee SS. Requirements for evidence-based management competency in healthcare: a scoping review. Front Public Health. [Internet]. 2025. [citado el 7 de septiembre de 2025]. 13:1490454. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11810947/
20. Khan ZA, Muzzamil U, Ahsan K, Khan A, Jawaid M. Barriers of conducting and completing research in Pakistan among doctors: A cross-sectional survey. Pak J Med Sci. [Internet]. 2025. [citado el 22 de agosto de 2025]. 41(3):886-890. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11911738/
21. Al-Kubaisi KA, Elnour AA, Sadeq A. Factors influencing pharmacists’ participation in continuing education activities in the United Arab Emirates: insights and implications from a cross-sectional study. J Pharm Policy Pract. [Internet]. 2023. [citado el 21 de agosto de 2025]. 16(1). Disponible en: https://www.tandfonline.com/doi/full/10.1186/s40545-023-00623-3
22. García Iraheta NG, Alemañy Pérez EJ, Carvajal Rodríguez C de los A. Desarrollo profesional continuo en la formación de profesionales sanitarios: desafíos, estrategias y perspectivas globales. Revista Cubana de Investigaciones Biomédicas. [Internet]. 2024 [citado el 28 de abril de 2026]. 43. Disponible en: https://revibiomedica.sld.cu/index.php/ibi/article/view/3709
23. Sherman L, Leon-Borquez R, Lopez M, Chappell K. An Overview of Continuing Medical Education/Continuing Professional Development Systems in Latin America: A Mixed Methods Assessment. Journal of CME. [Internet]. 2024. [citado el 22 de agosto de 2025]. 13(1). Disponible en: https://www.tandfonline.com/doi/full/10.1080/28338073.2024.2427765
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Noe Geovanni García Iraheta, Eduardo Joaquín Alemañy Pérez, Cirelda de los Ángeles Carvajal Rodríguez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have published with this journal, accept the following terms:
a. The authors will keep their copyright and guarantee the magazine the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution License that allows third parties to share the work as long as the author and first publication of this magazine are indicated.
b. The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) as long as the initial publication in this journal is indicated.
c. Authors are allowed and recommended to disseminate their work through the Internet (e.g.: in institutional telematic archives or in their web page) before and during the submission process, which may produce interesting exchanges and increase the number of citations of the published work. (See The effect of open access).
